Information Provided By: 
Fly News Breaks for June 14, 2017
ALXN
Jun 14, 2017 | 08:16 EDT
JPMorgan analyst Anupam Rama believes Alexion Pharmaceuticals' management team now looks to be in place following yesterday's announcement that Paul Clancy would be joining the company as Chief Financial Officer. The team will need more time on the business development side, making shares more likely to be range-bound in the near-to-intermediate term, Rama tells investors in a research note. The analyst keeps a Neutral rating on Alexion.
News For ALXN From the Last 2 Days
There are no results for your query ALXN
